Trial Profile
Prospective trial of Risperdal (risperidone) following psychological therapy for challenging behaviour in learning disabled children.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Apr 2010
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Behavioural disorders
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 30 Mar 2010 Actual patient number (19) added as reported by ClinicalTrials.gov.
- 19 Oct 2007 Status changed from in progress to completed.
- 28 Oct 2006 New trial record.